title: Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
authors.forename: P J
authors.initials: PJ
authors.lastname: Hayden
authors.forename: N
authors.initials: N
authors.lastname: Gardiner
authors.forename: K
authors.initials: K
authors.lastname: Molloy
authors.forename: J
authors.initials: J
authors.lastname: Ryan
authors.forename: M
authors.initials: M
authors.lastname: Lawler
authors.forename: S R
authors.initials: SR
authors.lastname: McCann
mesh_terms: D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility / Q000188:drug therapy*; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000017:ABO Blood-Group System; D016572:Cyclosporine